US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 26, 2013 (14 years ago)

Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.

What was recalled

Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887

Recalling firm
Sanofi-Synthelabo
Origin
Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-886-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rifampin recalls

See all